Kailera Therapeutics, Inc. (KLRA)
16.54
-0.63
(-3.67%)
USD |
NASDAQ |
Aug 24, 16:00
16.54
0.00 (0.00%)
After-Hours: 20:00
Kailera Therapeutics Total Liabilities (Quarterly) : 92.95M for June 30, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 92.95M |
| Date | Value |
|---|---|
| March 31, 2026 | 64.48M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Moderna, Inc. | 4.20B |
| Revolution Medicines, Inc. | 1.717B |
| Sana Biotechnology, Inc. | 276.95M |
| Parabilis Medicines, Inc. | 127.53M |
| Arrowhead Pharmaceuticals, Inc. | 1.646B |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 1.211B |
| Shareholders Equity (Quarterly) | 1.118B |
| Debt to Equity Ratio | 0.0091 |
| Current Ratio | 11.11 |